Senior insider sale
Chief Development Officer at ALDEYRA THERAPEUTICS, INC. — senior position signals high conviction
$81.8K
16.04K shares
What this filing means
MACHATHA STEPHEN plans to sell 16.04K shares of ALDEYRA THERAPEUTICS, INC. valued at approximately $81.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2024ACC: 0001928391-24-000001
Officer· Chief Development Officer
Since Dec 2020
16.04K
Shares to sell
$81.8K
Approx. market value
185.60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Award
Services rendered
7/15/2022
185.60KTotal acquired185.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/15/2022 | Restricted Stock Unit Award Services rendered | 185.60K | — |
| Total | 185.60K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
16.04K
Market value
$81.8K
8/12/2024
Total
Units
16.04K
Value
$81.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/12/2024 | 16.04K | $81.8K | Nasdaq | Planned |
| Total | 16.04K | $81.8K | ||